已发表论文

关联挖掘发现 MAL2 是一种新型的结直肠癌抑癌基因

 

Authors Wang K , Yang Y, Zheng S , Hu W

Received 6 April 2022

Accepted for publication 4 July 2022

Published 9 July 2022 Volume 2022:15 Pages 761—769

DOI https://doi.org/10.2147/OTT.S369670

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Arseniy Yuzhalin

Introduction: Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. However, the driver genes that promote CRC metastasis remain poorly understood. Association mining mines and extracts the repeated correlations and relevance in a dataset to predict the appearance of other data items according to the appearance of one item.
Methods: Here, the Apriori algorithm was used to find the frequent mutational gene sets (FMGSs) and hidden association rules (ARs) within these FMGSs from 383 CRCs with whole exome sequencing datasets. The weighted correlation network analysis (WGCNA) was used to identify the hub genes in CRC. CCK8, colony formation, cell migration and invasion assays were adopted to detect the roles of hub genes in CRC.
Results: Intriguingly, we found that MAL2 (myelin and lymphocyte protein 2) was associated with TP53 and APC in stage IV of CRC, and further subnetwork exploration based on WGCNA identified MAL2 as a potent hub gene. To validate the metastasis-related role of MAL2 in CRC, a lentivirus-based overexpression system was utilized to construct MAL2-overexpressing human CRC LOVO cells. Overexpression of MAL2 remarkably inhibited CRC cell proliferation and invasion.
Conclusion: Our results highlighted that MAL2 acts as a tumor suppressor in CRC and could serve as a potential therapeutic target.
Keywords: Apriori, CRC, frequent mutational gene sets, MAL2